biosensis fine bioscience tools - antibodies, elisa kits, proteins, toxins and peptides An Australia-US partnershipPhone: 1800 605 5127 in the US, or +61 8 8352 7711 for international enquiries to Australia.
HomeAbout BiosensisBiosensis distributorsResourcesHelp deskordering from BiosensisContact usFlyers

Technical Notes
View our tech notes
Follow us...
Google+ Follow us on Twitter

Find us on Facebook

Sign up for Biosensis newsletters
Visit our newsletter archive
News and Site Information.

Parkinsons Disease Biomarkers


Dear Researcher,

Levels of α-synuclein monomer and its oligomeric, aggregated and phosphorylated forms are well known to change in Parkinson’s Disease. An excellent review by Parnetti et al. (2019), published in Lancet Neurology, discusses the Biomarker potential of α-synuclein isoforms and their clinical utility.

Biosensis is addressing the need for reliable and accurate quantification of α-synuclein by releasing its NEW RapidTM ELISA Kit for this important target (BEK-2216). It represents the first assay in Biosensis’ collection of α-synuclein ELISA kits, with more kits in development!

Our new α-synuclein RapidTM ELISA Kit features:

·     Real validation data on accurate quantification in human blood and CSF
·     Low intra- and inter-assay CVs of < 10%
·     Complete kit with precise instructions
·     Fast (< 4 hours) and reliable assay performance
For more details on our α-synuclein RapidTM ELISA Kit, please find our protocol here, or contact us at

Good luck with your research,

The Biosensis Team